JPS51133489A - Process for producing microbial components of pseudomonas aeruginosa h aving antimicrobial and antitumor activities - Google Patents

Process for producing microbial components of pseudomonas aeruginosa h aving antimicrobial and antitumor activities

Info

Publication number
JPS51133489A
JPS51133489A JP50055979A JP5597975A JPS51133489A JP S51133489 A JPS51133489 A JP S51133489A JP 50055979 A JP50055979 A JP 50055979A JP 5597975 A JP5597975 A JP 5597975A JP S51133489 A JPS51133489 A JP S51133489A
Authority
JP
Japan
Prior art keywords
aving
antimicrobial
pseudomonas aeruginosa
producing microbial
antitumor activities
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP50055979A
Other languages
English (en)
Japanese (ja)
Other versions
JPS6123167B2 (OSRAM
Inventor
Son Honma
Chiyoji Abe
Kenichi Tanamoto
Kazuo Taruya
Akio Hoshi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Tokyo NUC
Original Assignee
University of Tokyo NUC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Tokyo NUC filed Critical University of Tokyo NUC
Priority to JP50055979A priority Critical patent/JPS51133489A/ja
Priority to GB5938/76A priority patent/GB1537509A/en
Priority to SE7601841A priority patent/SE434701B/xx
Priority to NO760646A priority patent/NO148338C/no
Priority to CA246,619A priority patent/CA1060797A/en
Priority to FR7605759A priority patent/FR2311093A1/fr
Priority to DE2610504A priority patent/DE2610504C2/de
Priority to US05/668,564 priority patent/US4079126A/en
Publication of JPS51133489A publication Critical patent/JPS51133489A/ja
Publication of JPS6123167B2 publication Critical patent/JPS6123167B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/104—Pseudomonadales, e.g. Pseudomonas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/005—Glycopeptides, glycoproteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/874—Pseudomonas
    • Y10S435/875—Pseudomonas aeruginosa

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Peptides Or Proteins (AREA)
JP50055979A 1975-03-12 1975-05-14 Process for producing microbial components of pseudomonas aeruginosa h aving antimicrobial and antitumor activities Granted JPS51133489A (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
JP50055979A JPS51133489A (en) 1975-05-14 1975-05-14 Process for producing microbial components of pseudomonas aeruginosa h aving antimicrobial and antitumor activities
GB5938/76A GB1537509A (en) 1975-05-14 1976-02-16 Method of preparing a component consisting of sugar lipid and protein derived from pseudomonas aeruginosa which possesses anti-tumor and interferon-inducing properties
SE7601841A SE434701B (sv) 1975-05-14 1976-02-18 Sett att framstella tumorbekempande infektionsforhindrande och interferoninducerande bakteriekomponent ur pseudomonas aeruginosa
NO760646A NO148338C (no) 1975-03-12 1976-02-26 Fremgangsmaate ved fremstilling av endotoxinprotein fra celleveggen hos pseudomonas aeruginosa
CA246,619A CA1060797A (en) 1975-05-14 1976-02-26 Isolation of original protein endotoxin from pseudomonas aeruginosa
FR7605759A FR2311093A1 (fr) 1975-05-14 1976-03-01 Procede de preparation d'un composant consistant d'un sucre, d'un lipide, d'une proteine, derive de la pseudomonas aeruginosa qui possede des proprietes inductrices antitumeur et d'intervention
DE2610504A DE2610504C2 (de) 1975-05-14 1976-03-12 Eine von Pseudomonas aeruginosa stammende Komponente aus Zucker, Lipoid und Protein, mit Antitumor- und Interferon bildenden Eigenschaften
US05/668,564 US4079126A (en) 1975-05-14 1976-03-19 Method of preparing a component consisting of sugar, lipid and protein derived from Pseudomonas aeruginosa which possess anti-tumor and interferon inducing properties

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP50055979A JPS51133489A (en) 1975-05-14 1975-05-14 Process for producing microbial components of pseudomonas aeruginosa h aving antimicrobial and antitumor activities

Publications (2)

Publication Number Publication Date
JPS51133489A true JPS51133489A (en) 1976-11-19
JPS6123167B2 JPS6123167B2 (OSRAM) 1986-06-04

Family

ID=13014183

Family Applications (1)

Application Number Title Priority Date Filing Date
JP50055979A Granted JPS51133489A (en) 1975-03-12 1975-05-14 Process for producing microbial components of pseudomonas aeruginosa h aving antimicrobial and antitumor activities

Country Status (7)

Country Link
US (1) US4079126A (OSRAM)
JP (1) JPS51133489A (OSRAM)
CA (1) CA1060797A (OSRAM)
DE (1) DE2610504C2 (OSRAM)
FR (1) FR2311093A1 (OSRAM)
GB (1) GB1537509A (OSRAM)
SE (1) SE434701B (OSRAM)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1085293A (en) * 1976-02-05 1980-09-09 Yuzuru Homma Toxoids derived from protease and elastase of pseudomonas aeruginosa and production thereof
JPS5296729A (en) * 1976-02-05 1977-08-13 Shionogi & Co Ltd Mixed vaccin for cyanomycosis
US4479935A (en) * 1980-04-22 1984-10-30 Institut Pasteur Fractions extracted from aerobic bacteria, endowed with antitumoral, antibacterial and interferon inducing properties, and process for their preparation
CA1256370A (en) * 1984-02-24 1989-06-27 Yuzuru Homma Toxoids of elastase of pseudomonas aeruginosa origin
AT384032B (de) * 1985-01-14 1987-09-25 Immuno Ag Verfahren zur herstellung von polydispersen nativen pseudomonas-flagella(h)-antigenen (fag)
US5179001A (en) * 1985-09-27 1993-01-12 The Regents Of The University Of California Detection and monitoring of chronic and gram-negative infection
US5237053A (en) * 1986-06-24 1993-08-17 Immuno Aktiengesellschaft Preparation active against Pseudomonas aeruginosa infections and methods of producing them
AT391080B (de) * 1986-06-24 1990-08-10 Immuno Ag Verfahren zur herstellung von gegen pseudomonas aeruginosa infektionen wirksamen praeparationen
FR2613380B1 (fr) * 1987-04-06 1989-11-17 Pasteur Institut Nouvelle substance adjuvante de certains antimitotiques chimiques, procede d'obtention de cette substance a partir de cultures de vibrio cholerae, agents therapeutiques contenant ladite substance
US6406696B1 (en) 1989-10-27 2002-06-18 Tolerance Therapeutics, Inc. Methods of stimulating the immune system with anti-CD3 antibodies
EP0497883B1 (en) * 1989-10-27 1998-07-15 Arch Development Corporation Compositions and their use for promoting immunopotentiation
US6491916B1 (en) 1994-06-01 2002-12-10 Tolerance Therapeutics, Inc. Methods and materials for modulation of the immunosuppresive activity and toxicity of monoclonal antibodies
US20030108548A1 (en) * 1993-06-01 2003-06-12 Bluestone Jeffrey A. Methods and materials for modulation of the immunosuppressive activity and toxicity of monoclonal antibodies
SG177944A1 (en) * 2005-07-11 2012-02-28 Macrogenics Inc Methods for the treatment of autoimmune disorders using immunosuppressive monoclonal antibodies with reduced toxicity
AU2007260687B2 (en) * 2006-06-14 2013-12-12 Provention Bio, Inc. Methods for the treatment of autoimmune disorders using monoclonal antibodies with reduced toxicity
EP2094302A4 (en) * 2006-12-21 2010-12-08 Macrogenics Inc METHODS FOR THE TREATMENT OF LADA-LIKE DIABETES AND OTHER AUTOIMMUNE DIABETES OF THE ADULT USING IMMUNOSUPPRESSANT MONOCLONAL ANTIBODIES HAVING REDUCED TOXICITY
KR20140147657A (ko) * 2011-03-02 2014-12-30 제롬 쉔타그 단독으로 또는 c형 간염 바이러스 감염과 결합되는 간 지방증의 치료를 위한 조성물, 방법 및 진단
CN109401992B (zh) * 2017-08-18 2021-07-23 黑龙江省科学院微生物研究所 一株高产内毒素蛋白的铜绿假单胞菌及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS496096B1 (OSRAM) * 1970-09-30 1974-02-12
FR2111719B1 (OSRAM) * 1970-10-20 1975-02-07 Yuzuru Homma
FR2184531B1 (OSRAM) * 1972-05-19 1975-10-17 Anvar

Also Published As

Publication number Publication date
SE434701B (sv) 1984-08-13
FR2311093B1 (OSRAM) 1979-06-29
JPS6123167B2 (OSRAM) 1986-06-04
SE7601841L (sv) 1976-11-15
US4079126A (en) 1978-03-14
CA1060797A (en) 1979-08-21
DE2610504C2 (de) 1985-07-11
GB1537509A (en) 1978-12-29
FR2311093A1 (fr) 1976-12-10
DE2610504A1 (de) 1976-11-25

Similar Documents

Publication Publication Date Title
JPS51133489A (en) Process for producing microbial components of pseudomonas aeruginosa h aving antimicrobial and antitumor activities
ES468123A1 (es) Procedimiento para la preparacion de nuevos compuestos fta- locianinicos sulfonados
ES451018A1 (es) Un procedimiento para preparar nuevos derivados de bencimi- dazol.
ES451117A1 (es) Un procedimiento para preparar 3-piridil-isoxazolidinas.
SE7601140L (sv) Sett att reglera tillvexten av alger
AU515421B2 (en) Treatment of bacterial infections with pseudomonic acid
IT7926201A0 (it) Antibiotico prodotto da microorganismi del genere pseudomonas e relativo procedimento di preparazione.
BG31505A3 (en) Composition containing alcohol
ES453508A1 (es) Un procedimiento para la preparacion de nuevas sustancias antibioticas desacetil-89oa1 y desacetil-89oa2.
JPS5231001A (en) Novel antibiotics-complex
ES466057A1 (es) Un procedimiento para preparar compuestos de 4"-desoxi-4"- amino-eritromicina a.
ES461267A1 (es) Un procedimiento para producir n-aminosulfenilcarbamatos.
ES465168A1 (es) Procedimiento de produccion de 3',4'-didesoxikanamicina bŸ
FR2324232A1 (fr) Procede de protection antimicrobienne de substrats
JPS51142532A (en) Inhibitors against microorganisms
JPS5218888A (en) Preparation of fortimicin c
JPS5414513A (en) Novel composition
JPS51134056A (en) High-speed direct-connected differential amplifier
IE35441B1 (en) 3-acyloxypropyl-2'-trimethylammoniumethyl phosphates
JPS51123821A (en) An algicide and protective agent
JPS51132903A (en) Light transmission apparatus
EP0043976A3 (en) Anti-tumor agent
IE44268L (en) 2 h-pyran-2, 6(3h) - dione derivatives
JPS5391123A (en) Antibacterials
ES229863Y (es) Registro de numeros telefonicos.